You just read:

New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants

News provided by

QIAGEN N.V.

Feb 16, 2017, 02:20 ET